Medicines

Govt will curb manufacturing, sale of counterfeit medicines in UP: CM Yogi

The Uttar Pradesh government is committed to putting a stop on the manufacturing and sale of counterfeit medicines in the state, Chief Minister Yogi Adityanath said on Monday. Responding to a starred question raised by Samajwadi Party MLA Sachin Yadav during the Question Hour, the chief minister, in a written reply, said the government is taking stringent measures to curb this illicit trade. Yadav had asked whether the government intends to curb the manufacturing and sale of counterfeit medicines in the state and if details of actions taken against those involved would be presented before the House. The chief minister said the Food Safety and Drug Administration department has conducted a total of 24,492 enforcement actions, including 22,151 inspections and 2,341 raids. A total of 26,225 samples were collected, out of which 301 cases of counterfeit medicines were identified. Medicines valued at an estimated Rs 19.76 crore were seized, and legal cases were filed for 250 instances of

Flipkart's 10-minute medicine delivery to shake up online pharmacy market

Flipkart to launch 10-minute medicine delivery under its 'Flipkart Minutes' service, partnering with local chemists to tap into quick commerce and expand its online pharmacy footprint

Drug regulator CDSCO flags 3 drugs as spurious, 56 not of standard quality

CDSCO made the revelation in its monthly update for October; drugs include those used to treat acid reflux, lower cholesterol and reduce risk of heart disease

Alembic Pharmaceuticals gets USFDA nod for hypertension treatment capsules

Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic Diltiazem Hydrochloride extended-release capsules indicated for the treatment of hypertension. The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for Diltiazem Hydrochloride Extended-Release Capsules of strengths 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg, Alembic Pharmaceuticals Ltd (Alembic) said in a statement. These capsules are indicated for the treatment of hypertension. These capsules may be used alone or in combination with other antihypertensive medications. Moreover, Diltiazem Hydrochloride is also indicated for the management of chronic stable angina and angina due to coronary artery spasm, the company said. Diltiazem Hydrochloride extended-release capsules 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg have an estimated market size of USD 105.3 million for the 12 months ended June 2024, the company ...

Teva faces fine for disparaging rival multiple sclerosis medicine: Report

The EU competition enforcer's tough line underscores its concerns that such practices could stifle innovation in the pharmaceutical industry

Special medical stores to be opened in tehsils for AYUSH medicines: Jadhav

Union Minister Prataprao Jadhav on Monday said special medical stores will be opened in every tehsil of the country to ensure adequate availability of AYUSH medicines. The Union AYUSH Minister also said the government is mulling on ways to ensure Ayurvedic medicines based on traditional knowledge get due recognition. "The traditional knowledge of Ayurveda has been passed on from generation to generation. There are very good medicines in Ayurveda, but they have no recognition. We are wondering how these drugs can be recognised," he told PTI here. "Only a few AYUSH medicines are available in common medical stores, due to which patients and doctors prescribing these medicines face problems. The government wants to ensure AYUSH drugs come into the market in abundance after research. These medicines should be available everywhere. For this, we are trying to open at least one special medical store of AYUSH medicines in every tehsil of the country," he said. AYUSH hospitals are also being

Glenmark Pharma introduces generic eye treatment medication in US

Glenmark Pharmaceuticals on Monday said its US-based subsidiary has introduced a generic medication used for eye itching. Glenmark Therapeutics Inc, USA has launched Olopatadine Hydrochloride Ophthalmic Solution (OTC) in the US market, the Mumbai-based drug maker said in a regulatory filing. Fabio Moreno, Head of OTC Sales & Marketing, Glenmark Pharmaceuticals Inc, said the launch of Olopatadine Ophthalmic Solution (USP, 0.1 per cent), addresses a growing demand for a new supplier in this category. "This addition highlights our commitment to meeting market needs and providing high-quality over-the-counter solutions for our customers," Moreno said.

‘Allopathy medicines are poison’: Baba Ramdev lands into hot waters

Govt plans regulatory crackdown on similar-sounding, look-alike drug brands

Drug manufacturers in India will soon be required to upload their product formulations and brand names on the government's portal

Online pharmacy players look for regulatory framework for industry

A division bench of the Madras HC has set aside an earlier order that disallowed them to engage in digital sale of medicines

Govt planning regulatory crackdown on look-alike, sound-alike drug names

In order to safeguard patients, the Drug Technical Advisory Board (DTAB) proposed banning the production and marketing of distinct drugs under identical brand names

AstraZeneca aims to grow its total revenue by 75% to $80 bn by 2030

The Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier expected to launch at least 15 new medicines between 2023 and 2030

Doctors not mandated to inform patients on drug side effects: Delhi HC

Delhi High Court dismissed a public interest litigation that sought to enforce the compulsory disclosure of drug side effects by doctors to the patients

World Homeopathy Day 2024: All about Homoeopathy and its benefits

The target of homoeopathy is to address and to give therapy the whole of an individual, including their character, way of life, hereditary predispositions, and disease history

5 dead, over 100 hospitalised from recalled Japanese health supplements

Kobayashi Pharmaceutical Co. came under fire for not going public quickly with problems known internally as early as January

Misleading ads case: SC orders Ramdev, Balakrishna to appear in person

Patanjali Ayurved has faced scrutiny from the top court for disseminating misleading advertisements that claim to treat medical conditions, a violation of the Magic Remedies Act, 1954

Centre seeks more time to frame policy on online sale of medicines

The Centre has urged the Delhi High Court to grant some time to frame a policy on the online sale of medicines on the grounds that the issue was "complex" and any modification in the manner of sale of drugs would have far-reaching consequences. The high court granted the Union Ministry of Health and Family Welfare four months as a last and final opportunity to frame the policy. A bench of Acting Chief Justice Manmohan and Justice Manmeet PS Arora made clear that "if the draft policy is not prepared before the next date of hearing, this court will have no other option but to proceed ahead with the matter". The high court, which was hearing several petitions seeking a ban on the "illegal" sale of drugs online and challenging the draft rules published by the ministry to further amend the Drugs and Cosmetics Rules, listed the matter for further hearing on July 8. It had earlier asked the Centre to file a status report on the petitions. During the recent hearing, the joint secretary of

Govt revamps pharma scheme, to provide financial assistance to drug cos

Financial support for drug companies also comes against the backdrop of deaths being reported abroad due to the manufacture of substandard drugs linked to Indian companies

7 in 10 Indians opt for nutraceuticals; most don't consult doctors: Survey

The survey by LocalCircles also highlighted that 68 per cent of nutraceutical users buy them from local medical or general stores

India sends relief material including medicines to cholera-affected Zambia

India has sent relief material, including medicines, to Zambia to help it deal with an outbreak of cholera, External Affairs Minister S Jaishankar said on Saturday. He said India stands with Zambia in this "trying time". "India sends Humanitarian Assistance to Zambia in wake of the cholera outbreak," Jaishankar posted on X along with a photograph of relief material consignments. "The aid weighing approx 3.5 tons comprises water purification supplies, chlorine tablets and ORS sachets. Was handed over today by our High Commissioner to the Government of Zambia," he said.